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Ischemic stroke (IS) is characterized by the sudden loss of blood circulation to 
an area of the brain originated as an occlusion of a cerebral vessel. In industrialized 
countries stroke is the major cause of death and long-term disability in adults. 
Its consequences impose a burden on patients, payers, and society in terms of 
cost of care and lost productivity. Taking into account that his burden is expected to rise 
over the coming decades due to number of elderly people are increasing in industrialized 
countries.  
Currently, the diagnosis relies on neurological assessment of the patient and 
neuroimaging techniques. A clinical goal for decades has been the identification of 
biomarkers of impending stroke in asymptomatic subjects and clinical prognosis in 
stroke patients. One of the potential of the proteomics is to detect novel drug targets and 
diagnostic markers, useful for disease detection, in easily obtained body fluids, like 
plasma or urine. 
The aim is to identify and to validate plasma proteins associated with IS 
phenotypes in order to find potential biomarkers disease and therapeutic targets to assist 
in the development of rapid diagnostic tests.  
5 IS patients and 5 healthy volunteers as controls were studied. Plasma samples 
were fractioned by depletion using the affinity column MARS-14 (Agilent 
technologies). Proteomic analysis was performed of fractionated plasma by 2D-DIGE, 
seeking to identify low dynamic range proteins involved in the disease process. 
40 spots with altered expression levels (average ratio≥1,5) were found and 
identified by MS/MS. We expect that this analysis provides additional information to 
enable us to deepen our knowledge of physiology and etiology of the disease, and the 
identification of proteins with possible diagnostic and therapeutic value. 
